评估日本破裂腹主动脉瘤优先腔内修复策略的有效性与临床结局
本研究比较日本3家医院163例破裂腹主动脉瘤患者,开放手术组53例(2012年1月前回顾性收集),EVAR优先策略组110例(2012年2月起按湘南rAAA方案前瞻性收集)。EVAR优先组30天死亡率25% vs 开放手术组42%(OR 0.44,95%CI 0.20-0.97),匹配队列(n=50)中为22% vs 44%(OR 0.35,95%CI 0.14-0.90),3年生存率在匹配队列中EVAR优先组63% vs 开放手术组45%(p=0.003)。
要点
- EVAR优先策略组30天术后死亡率为25%,开放手术组为42%(OR 0.44,95%CI 0.20-0.97)。
- 匹配队列(n=50)中EVAR优先组30天死亡率为22%,开放手术组为44%(OR 0.35,95%CI 0.14-0.90)。
- 匹配队列中EVAR优先组3年生存率为63%,开放手术组为45%(p=0.003)。
核心结论
- 基于湘南rAAA方案的EVAR优先策略治疗破裂腹主动脉瘤的结局显著优于开放手术策略。
- 这些发现提示,鉴于EVAR具有降低早期死亡率的潜力,应考虑将其作为破裂腹主动脉瘤的主要治疗选择。
研究设计与样本
- 本研究纳入2007年1月至2016年9月在日本神奈川县3家医院接受手术治疗的破裂腹主动脉瘤患者,比较开放手术组与EVAR优先策略组的短期和长期治疗结局。
- 开放手术组为2012年1月前接受开放手术的患者,数据从病历中回顾性收集;EVAR优先策略组为2012年2月及以后按湘南rAAA方案(SRAP,标准化方案为基础的EVAR优先策略)治疗的患者,数据前瞻性收集。
- 另采用基于风险评分的敏感性分析(一对一匹配),卡钳值为评分的0.2个标准差。
主要发现
- 163例破裂腹主动脉瘤患者中,开放手术组53例,EVAR优先策略组110例(EVAR占91.8%,开放修复占8.2%)。
- 30天术后死亡率开放手术组为42%,EVAR优先策略组为25%(OR 0.44,95%CI 0.20-0.97)。
- EVAR优先组术后6个月、1年、3年生存率分别为66%、48%、58%,开放手术组分别为51%、66%、48%(p=0.072)。
- 匹配队列分析(n=50)中,30天术后死亡率EVAR优先组为22%,开放手术组为44%(OR 0.35,95%CI 0.14-0.90)。
- 匹配队列中,EVAR优先组术后6个月、1年、3年生存率分别为76%、76%、63%,开放手术组分别为48%、45%、45%(p=0.003)。
临床怎么用
- 作者认为,鉴于EVAR具有降低早期死亡率的潜力,应考虑将其作为破裂腹主动脉瘤的主要治疗选择。
- 本研究支持在日本使用基于湘南方案的EVAR优先策略治疗破裂腹主动脉瘤,该策略较传统开放手术改善了结局、降低了30天术后死亡率并提高了长期生存率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To verify the validity of an endovascular aneurysm repair (EVAR)-first strategy for treating patients with ruptured abdominal aortic aneurysm (rAAA) in Japan. MATERIALS AND METHODS: This study was conducted on 2 groups of patients with rAAA who underwent surgical treatment at 3 hospitals in the Kanagawa Prefecture, Japan, between January 2007 and September 2016. The open surgical treatment group comprised patients with rAAA who underwent open surgical treatment before January 2012; their data were retrospectively collected from their medical records. The EVAR-first strategy group comprised patients with rAAA who underwent treatment based on the Shonan rAAA protocol (SRAP; the standard protocol-based EVAR-first strategy) in or after February 2012; their data were collected prospectively. The short- and long-term treatment outcomes of both groups were compared. In addition, a risk score-based sensitivity analysis (one-to-one matching) was conducted on both groups using a caliper with 0.2 standard deviations of the score. RESULTS: Of the 163 patients with rAAA, the open surgical and EVAR-first strategy groups comprised 53 and 110 patients, respectively (EVAR: 91.8%, open repair: 8.2%). The 30-day postoperative mortality rate differed significantly, being 42% for the open surgery group and 25% for the EVAR-first strategy group (odds ratio: 0.44, 95% confidence interval: 0.20-0.97). The postoperative survival rates at 6 months, 1 year, and 3 years were 66%, 48%, and 58% for the EVAR-first group, respectively, and 51%, 66%, and 48% for the open surgery group, respectively (p=0.072). In a matched cohort analysis (n=50), the 30-day postoperative mortality rate was 22% for the EVAR-first group and 44% for the open surgery group (odds ratio: 0.35, 95% confidence interval: 0.14-0.90). The postoperative survival rates at 6 months, 1 year, and 3 years were 76%, 76%, and 63% for the EVAR-first group, respectively, and 48%, 45%, and 45% for the open surgery group, respectively (p=0.003). CONCLUSION: The SRAP-based EVAR-first strategy for rAAA yielded significantly better treatment outcomes than the open surgical strategy. These findings suggest that EVAR should be considered the primary treatment option for rAAA, given its potential to reduce early mortality rates.Clinical ImpactMulticenter retrospective analysis of prospectively collected registry data was done to compare treatment outcomes of two groups of ruptured abdominal aortic aneurysm patients open surgery and endovascular-aneurysm-repair (EVAR)-first strategy (Shonan ruptured abdominal aortic aneurysm protocol). EVAR-first group showed better outcomes: lower 30-day mortality (25% vs. 42%), higher survival rates at 6 months, 1 year, and 3 years. TAKE HOME MESSAGE: The study supports the use of the EVAR-first strategy with the Shonan Protocol for treating ruptured abdominal aortic aneurysms in Japan, showing improved outcomes, reduced 30-day postoperative mortality, and better long-term survival rates compared to the conventional approach.
引用
- Ogino H, Isogai N, Kume N, et al. Evaluating the Effectiveness and Clinical Outcomes of Endovascular Aneurysm Repair-First Approach for Ruptured Abdominal Aortic Aneurysm in Japan. J Endovasc Ther. 2024. PMID: 38659330. doi:10.1177/15266028241248337
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。